accuRPM
Remote Patient Monitoring service powered by Tellihealth
Platform · Cloud SaaSCompany source
Company profile
About Tellihealth
Tellihealth is a leader in Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and connected medical devices, delivering intelligent, seamless, and scalable remote care solutions that transform healthcare delivery beyond traditional clinical settings. The company combines real-time patient data, AI-driven insights, and personalized support to improve patient outcomes while reducing healthcare costs. Tellihealth's solutions feature full EHR integration, 24/7 patient monitoring, and a fully managed service model that ensures providers can focus on delivering high-quality, patient-centered care. The company operates through two primary service lines: accuRPM (Remote Patient Monitoring service of Accuhealth powered by Tellihealth) and signalCCM (Chronic Care Management service of Signallamp Health powered by Tellihealth). Tellihealth provides FDA-approved, 4G-enabled medical devices including blood pressure monitors, pulse oximeters, and thermometers that require no Bluetooth, Wi-Fi, or apps, making them plug-and-play solutions that auto-sync for ease of use and scalability. The company serves hospitals and health systems, multi-specialty practices, small practices, and specialist practices, helping them expand care beyond their facilities, drive revenue growth, reduce provider workload, and implement value-based care solutions. Guided by values of intelligence, innovation, and integrity, Tellihealth is on a mission to radically change the care delivery model by providing intelligent, personalized remote care solutions accessible anywhere.
Company description Tellihealth official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Tellihealth?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Chronic conditions
- Complex chronic needs
- Hypertension
- Kidney disease
- Nephrology conditions
Who it serves
- Federally Qualified Health Centers (FQHCs)
- Hospitals & Health Systems
- Multi-Specialty Practices
- Nephrology practices
- Small Practices
- Specialist Practices
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: EHR systems (unspecified vendors).
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Reimagined Tellihealth uniting Accuhealth, Signallamp Health, and leading RPM devices under unified brand; G0511 expansion for FQHCs
Partnerships
Recorded partners
- Accuhealth
- Levine Heart & Wellness
- Signallamp Health
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
signalCCM
Chronic Care Management service powered by Tellihealth
Platform · Cloud SaaSCompany source
Tellihealth Devices
FDA-approved, 4G-enabled medical devices for RPM and CCM
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
90-Day Stage II Hypertension Reduction
Monitored patients in 2024
$13M estimated healthcare savings
2024, averaging $13,500 per hospital stay prevented
Reduced hospital readmission rates
For hospitals and health systems
Prevented hospitalizations
2024 (specific number not disclosed in text)
Aggregate Customer Base
Stage II Hypertension management through RPM monitoring
90-Day Stage II Hypertension Reduction monitored in 2024; $0M estimated healthcare savings in 2024 (Avg. $13,500 per hospital stay); estimated number of hospitalizations prevented in 2024
Levine Heart & Wellness
Remote Patient Monitoring to provide proactive and attentive care
Case study available but specific metrics not disclosed in scraped content
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Asif Ahmad
Chief Executive Officer
Kevin Clark
Chief Financial Officer
John Kalivas
Chief Technology Officer
Jill Langenfeld
Chief Operating Officer
Anne Marie Law
Chief People and Culture Officer
Chuck Washburn
Chief Revenue Officer
Kim Johnson
Vice President of Customer Success
06 · Company updates
Updates from Tellihealth
Recent articles published on Tellihealth's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.